about
RASSF2 associates with and stabilizes the proapoptotic kinase MST2Global implementation of genomic medicine: We are not aloneOff-trial evaluation of bisphosphonates in patients with metastatic breast cancerFive futures for academic medicineThe molecular characteristics of colonic neoplasms in serrated polyposis: a systematic review and meta-analysisThe dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesisSubmillimetre galaxies reside in dark matter haloes with masses greater than 3 × 10¹¹ solar massesHerMES: Halo occupation number and bias properties of dusty galaxies from angular clustering measurementsDetection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritisSMAD2, SMAD3 and SMAD4 mutations in colorectal cancerKirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' studyReassembly of nucleosomes at the MLH1 promoter initiates resilencing following decitabine exposureFacilitating a culture of responsible and effective sharing of cancer genome dataLarge-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serumOesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: a population-based study using linked health administrative linked dataIsolation of antibodies which neutralise the activity of early pregnancy factor.Biodistribution of filamentous phage-Fab in nude mice.Can administrative data be used to measure chemotherapy side effects?Structural analysis of the ErbB-2 receptor using monoclonal antibodies: Implications for receptor signalling.The application of phage display in allergy research: characterization of IgE, identification of allergens and development of novel therapeutics.Application of phage display technology to cancer research.Analysis of IgE antibodies from a patient with atopic dermatitis: biased V gene usage and evidence for polyreactive IgE heavy chain complementarity-determining region 3.Selectable in-vivo recombination to increase antibody library size--an improved phage display vector system.Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscapeIdentification of 5 novel genes methylated in breast and other epithelial cancers.Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies.Checking the scoreboard: the impact of cancer genetics on clinical practice.Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells.Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines.The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cellsUptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online?The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.Does MSI-low exist?Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution.Current evidence does not support routine adjuvant radiotherapy for rectal cancer.Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.The quality of web-based oncology guidelines and protocols: how do international sites stack up?The relationship between hypomethylation and CpG island methylation in colorectal neoplasia.Colorectal cancer: a model for epigenetic tumorigenesis.
P50
Q24338394-0E6253FE-80AD-4B1E-AF98-BF9E0A68570AQ24658586-637498F5-8E8E-4A05-BB95-7899C590AE9BQ24811840-AA145C18-75F3-44B6-B8E2-74E705431F4BQ24815015-D26B68E9-B0EC-4DD6-B2D7-E6C7D8B85CFAQ26738611-3D0374EA-D54A-47E3-820E-579DB96C1806Q26829919-9E7AB5F1-9CA1-4C27-815E-B862EF0695A5Q27014149-966CF2ED-4496-43FE-B6B9-4EF3E47ED015Q27019552-0E875ACB-3C7C-4CA3-B5BE-C5617CAB2D91Q28258148-2BC9ADE7-270B-45D0-92D5-E82A55985538Q28278952-11AC1DCA-754A-405C-9310-A62187E7EB97Q28348036-71B388AE-D4F9-4C74-A35B-6C1FA0AC4033Q28534843-1A9648CF-5C99-4EC3-A831-B025B271AE79Q28597289-3529FEB6-EC0C-45AF-A487-A164640B1689Q30452357-59D67168-C7B0-4325-8231-924A17E26D73Q30576847-B056CA68-3C38-4CC5-B7B2-AD3FDAB0A99FQ30658267-4D451D19-17E0-4B26-8538-4D30AFCA443EQ30712958-802118E4-00FE-4058-A016-6AE81A6091CDQ30877306-D670D927-0A70-429C-9090-37659BF73317Q30885329-86A2A5FF-A039-4175-B941-0603F3C02415Q31006318-6B1C5C38-600E-4845-B266-C7856242DC0CQ31041774-3943DF69-5C4F-4683-A60A-45A2DE1C711AQ31072799-61D7F2DE-3409-4D04-AEFB-203C222AE081Q31916372-D8A02A61-F8A3-4749-B652-B4DC33874EAAQ33608185-8392BBB9-8173-4931-B154-1CF4188CC267Q33737079-C40B9713-0F90-4D79-8D41-B619EF26033AQ33851569-76B74676-8D0C-4B7D-B48D-D083310D62BEQ33984198-AAAADD96-93F5-49F6-9496-A9E43DE67580Q34309858-05399CBB-A5C7-489D-8737-EE6D0A785161Q34323763-587160A7-17EA-4FC6-A869-6FA35E290125Q34504368-E836EFA4-59DA-4E57-B143-1CDFB3174C95Q34552289-A7720A0B-AA65-44B4-92F8-F633BEF3E05DQ34622465-773F383C-64B0-4986-B82D-0900285F019FQ34644859-B24AE4BA-616A-4BB0-B4D9-ED405FC6253AQ34703122-4EA0F8EA-A70D-4E5D-969C-3488F57AECE9Q34946877-2DE93A40-81AD-483B-9696-42D3607A28E9Q35001162-0389E34B-1325-488A-8AF3-BD74ADC572A0Q35363901-14A08FD3-6361-4F50-B9B4-24F161E6D3A7Q35527152-27DBFF66-183B-4E8D-9926-92A87BAABB00Q35749254-8160B102-1AFC-4658-88C5-1F570EE6C392Q35761237-66D7FB77-2EE5-42FB-95DB-EA51937EAC5E
P50
description
Australian medical researcher
@en
taighdeoir leighis Astrálach
@ga
name
Robyn L Ward
@nl
Robyn L Ward
@sl
Robyn Ward
@ca
Robyn Ward
@en
Robyn Ward
@es
Robyn Ward
@fr
Robyn Ward
@ga
Robyn Ward
@sq
type
label
Robyn L Ward
@nl
Robyn L Ward
@sl
Robyn Ward
@ca
Robyn Ward
@en
Robyn Ward
@es
Robyn Ward
@fr
Robyn Ward
@ga
Robyn Ward
@sq
altLabel
Robyn L. Ward
@en
Robyn Lynn Ward
@en
prefLabel
Robyn L Ward
@nl
Robyn L Ward
@sl
Robyn Ward
@ca
Robyn Ward
@en
Robyn Ward
@es
Robyn Ward
@fr
Robyn Ward
@ga
Robyn Ward
@sq
P1053
I-2313-2013
P1153
56181066900
P1960
DYvbGKkAAAAJ
P21
P27
P31
P3829
P496
0000-0002-6877-8906